KromaTiD
KromaTiD provides molecular and genetic testing solutions for detecting disease-causing mutations including inversions and translocations in a single assay. Based on its patented Directional Genomic Hybridization (dGH) technology, KromaTiD's assays generate sequence, location, and orientation data from single cells, making them ideal for mixed cell population studies. Founded in 2007 and headquartered in Fort…
Funding snapshot
About
KromaTiD provides molecular and genetic testing solutions for detecting disease-causing mutations including inversions and translocations in a single assay. Based on its patented Directional Genomic Hybridization (dGH) technology, KromaTiD's assays generate sequence, location, and orientation data from single cells, making them ideal for mixed cell population studies. Founded in 2007 and headquartered in Fort Collins, United States, the company has raised approximately $15.4M in Series C funding from investors including Broadoak Capital Partners and NHGRI. KromaTiD's research products and services support deeper understanding of genetic diseases including cancers and developmental disorders, serving pharmaceutical companies, research institutions, and clinical laboratories with high-resolution chromosomal analysis tools.
Business model
Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Hybridization-based > Microarrays,
Life Sciences Platforms and Tools > Research Assays > Drug Discovery > Microarrays
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.